Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective | PTCE Pharmacy Connect

To claim CE credit for this activity, please follow this link: www.pharmacytimes.org/atopic-derm-podcast-630

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Educational Objectives

• Review patient barriers that impact optimal treatment of patients with atopic dermatitis (AD) who are seeking OTC care
• List strategies to individualize patient care and improve recommendations for AD

Moderator:

Mary Bridgeman, PharmD, BCPS, BCGP

Clinical Professor

Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey

Piscataway, New Jersey

 

Internal Medicine Clinical Pharmacist

Robert Wood Johnson University Hospital

New Brunswick, New Jersey

 

Faculty & Caregiver:

Ashley Ellis, PharmD, MBA, CDECS

ImPAcT Director & Assistant Professor

The University of Tennessee Health Science Center

Department of Clinical Pharmacy and Translation Science College of Pharmacy

Memphis, Tennessee

 

Mary Bridgeman, PharmD, BCPS, BCGP has no financial relationships with commercial interests to disclose.

Ashley Ellis, PharmD, MBA, CDECS, has the following financial relationships with commercial interests to disclose:

Grant/Research Support: Researcher AHRQ “Tennessee Heart Health Network” funding in form of salary release dollars

Consultant: Global Parents for Eczema Research, Continuing Education Alliance, McGraw Hill

 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-268-H01-P and 0290-0000-23-268-H01-T. The activity is available for CE credit through June 30, 2024.

This activity is supported by an educational grant from CeraVe and La Roche-Posay.

Brought to you in partnership with the National Eczema Association.